Factors associated with antithrombotic treatment decisions for stroke prevention in atrial fibrillation in the Stockholm region after the introduction of NOACs
Crossref DOI link: https://doi.org/10.1007/s00228-017-2289-0
Published Online: 2017-06-29
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Komen, Joris http://orcid.org/0000-0002-5471-3132
Forslund, Tomas
Hjemdahl, Paul
Wettermark, Björn
Funding for this research was provided by:
Stockholms Läns Landsting
Karolinska Institutet
Hjärt-Lungfonden
License valid from 2017-06-29